Damora Therapeutics (DMRA) Q1 2026 Earnings

19MarConfirmed
Q4 2025
Q1 2026
-3.24
-1.86
-0.48
0.9

Details

Expected EPS
0.902123
Actual EPS
-3.242888
Surprise EPS
-4.15
Surprise Percent
+459.47%

Description

Damora Therapeutics (DMRA) has reported earnings of -3.242888 per share for Q1 2026.

0 Comments

Share your thoughts